Inventors and entrepreneurs who don’t have a track record face the biggest challenges, a panel of experts said Friday morning at IBJ’s Life Sciences Power Breakfast.
If approved for weight loss, Eli Lilly’s tirzepatide could become the most effective drug to date in an arsenal of medications that are transforming the treatment of obesity, which affects more than 4 in 10 American adults and is linked to dozens of diseases.
The Indianapolis-based drugmaker said it would complete submission of tirzepatide to the U.S. Food and Drug Administration in coming weeks for treatment of obesity and expects regulatory action as early as late 2023.
Worldwide sales of Baqsimi totaled $139.3 million last year, representing less than 1% of Indianapolis-based Lilly’s worldwide revenue of $28.5 billion.
Fishers-based INCOG Biopharma Services Inc., one of the newest players in the $132 billion contract drug manufacturing industry, acts as a behind-the-scenes player for companies that need to get sterile injectable medicines to market in a hurry.
Brad Chambers envisions a Hoosier research triangle similar to North Carolina’s that spans West Lafayette, Indianapolis and Bloomington and capitalizes on the talent and assets our research universities provide for the industries of the future
Derik Wittenberg leads the team at Elanco Animal Health responsible for setting research and development priorities, developing business analytics to provide business insights, and improving operations.
A top official for the Indiana Economic Development Corp. said numerous companies are considering major investments in the planned advanced manufacturing and tech hub in Boone County known as the LEAP District.
The expansion will bring Eli Lilly and Co.’s total investment in the project to $3.7 billion, the most the company has ever spent on a single manufacturing site.
Fifty years ago, Indiana University reached the Final Four of the NCAA Basketball Tournament with the first and unlikeliest of Bob Knight’s five Final Four teams.
BiomEdit LLC was set up last year by Greenfield-based Elanco Animal Health and Boston-based Ginkgo Bioworks to make everything from food to therapeutics for animals. It’s already raised $36.5 million in venture capital for its work.
Patricia Martin, the group’s president and CEO since 2019, last month announced she would step down to examine opportunities in the private sector and urged industry leaders to take a fresh look at the organization.
A wave of adoptions during the COVID-19 pandemic has created greater demand for basics like food and toys, as well as sophisticated medical care that can prolong a pet’s life.
The Lebanon Plan Commission voted unanimously Monday to approve Eli Lilly and Co.’s development plan for its two manufacturing facilities in Boone County.
The National Institutes of Health awarded the grant to the Indiana Clinical and Translational Sciences Institute, a partnership among Indiana University, Purdue University and University of Notre Dame.
In downtown Indianapolis, where train lines hug the eastern and southern boundaries of the city’s Mile Square, a hazardous spill evacuation could affect more than 100,000 people—including office workers, residents, business owners and visitors, depending on the time of day.
